PRF Technologies (PRFX) Consolidated Net Income (2020 - 2025)
PRF Technologies' (PRFX) quarterly Consolidated Net Income came in at $6000.0 in Q2 2025, down 93.88% on a YoY basis from $98000.0 in Q2 2024, and down 93.88% quarter-over-quarter from $98000.0 in Q2 2024.
Powered by 
Analysis
PRF Technologies (PRFX) Consolidated Net Income (2020 - 2025) Analysis & Trends
PRF Technologies (PRFX) has reported Consolidated Net Income for 6 consecutive years, with $6000.0 the latest figure, recorded in Q2 2025.
- For the quarter ending Q2 2025, Consolidated Net Income fell 93.88% year-over-year to $6000.0; the trailing twelve-month figure through Jun 2025 stood at -$9.0 million (up 13.08% YoY), and the FY2025 full-year result was -$5.0 million, up 65.65% from the prior year.
- Consolidated Net Income retreated to $6000.0 in Q2 2025 per PRFX's latest filing, from $98000.0 in the prior quarter.
- Across five years, Consolidated Net Income topped out at $98000.0 in Q2 2024 and bottomed at -$5.6 million in Q1 2024.
- Historically, Consolidated Net Income has averaged -$2.1 million across 5 years, with a median of -$1.8 million in 2022.
- The sharpest annual moves came in 2021 and 2024: Consolidated Net Income tumbled 1444.7% in 2021, then jumped 104.35% in 2024.
- Over 5 years, Consolidated Net Income stood at -$1.7 million in 2021, then plunged by 87.02% to -$3.3 million in 2022, then dropped by 9.46% to -$3.6 million in 2023, then surged by 102.75% to $98000.0 in 2024, then tumbled by 93.88% to $6000.0 in 2025.
- According to Business Quant data, Consolidated Net Income over the past three periods registered $6000.0, $98000.0, and -$5.6 million for Q2 2025, Q2 2024, and Q1 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn | -576.00 Mn |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn | -118.80 Mn |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn | 45.93 Mn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn | 69.61 Mn |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn | 260.00 Mn |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn | 24.70 Mn |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn | -66.70 Mn |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn | 30.35 Mn |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn | 1.97 Mn |
| 10 | PRF Technologies | 622,054.07 | -10.31 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 6,000.00 |
| Jun 30, 2024 | 98,000.00 |
| Mar 31, 2024 | -5.57 Mn |
| Dec 31, 2023 | -3.56 Mn |
| Sep 30, 2023 | -1.35 Mn |
| Jun 30, 2023 | -2.25 Mn |
| Mar 31, 2023 | -2.42 Mn |
| Dec 31, 2022 | -3.26 Mn |
| Sep 30, 2022 | -2.10 Mn |
| Jun 30, 2022 | -1.85 Mn |
| Mar 31, 2022 | -1.67 Mn |
| Dec 31, 2021 | -1.74 Mn |
| Sep 30, 2021 | -1.77 Mn |
| Jun 30, 2021 | -1.66 Mn |
| Mar 31, 2021 | -2.04 Mn |
| Dec 31, 2020 | -691,000.00 |
| Sep 30, 2020 | -700,000.00 |
| Jun 30, 2020 | -148,000.00 |
| Mar 31, 2020 | -132,000.00 |
API Access
PRF Technologies Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=PRFX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "PRFX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=PRFX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();